CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited) (Tables)

3 Months Ended

Oct. 31, 2025

Condensed Financial Information Disclosure [Abstract]

Schedule of balances sheet

	October 31,			July 31,
	2025			2025
ASSETS
Cash	$	800,865		$	2,177,414
Prepaid expense		56,250			39,373
Receivable to subsidiaries		1,647,584			497,584
Investment in subsidiaries		1,859,218			288,614
Total Assets	$	2,716,333		$	3,002,985
LIABILITIES
Accounts payable and other accrued liabilities	$	125		$	18,679
Due to related parties		–			–
		125			18,679
Stockholders’ equity
Series A Preferred stock, $0.0001 par value; 80,000 shares authorized; no shares issued and outstanding as of October 31, 2025 and July 31, 2025		–			–
Series B Preferred stock, $0.0001 par value; 80,000 shares authorized; 80,000 shares issued and outstanding as of October 31, 2025 and July 31, 2025		8			8
Undesignated preferred stock, $0.0001 par value; 19,920,000 shares authorized; no shares issued and outstanding		–			–
Common stock, $0.0001 par value, 100,000,000 shares authorized; 16,531,803 shares issued and outstanding as of October 31, 2025 and July 31, 2025		1,653			1,653
Additional paid-in capital		5,845,505			5,845,505
Accumulated deficit		(3,130,958	)		(2,862,860	)
Total stockholders’ equity		2,716,208			2,984,306
Total Liabilities and Stockholders’ Equity	$	2,716,333		$	3,002,985

Schedule of statement of operations

	For the three months ended October 31,
	2025			2024
EXPENSE:
General and administrative	$	(256,709	)	$	(130,415	)
Selling and marketing		(4,410	)		–
OTHER INCOME
(Loss) gain from investment in subsidiaries		(6,979	)		9,968
Other income (expense) net		–			27,391
Total other (expense) income		(6,979	)		37,359
Net (loss)	$	(268,098	)	$	(93,056	)

Schedule of statement of cash flow

	For the three months ended October 31,
	2025			2024
Cash flows from operating activities:
Net (loss)	$	(268,098	)	$	(93,056	)
Adjustments to reconcile net income to net cash (used in) operating activities:
Warrants issuance to consultant		–			–
Share of (gain) from investment in subsidiaries		6,979			(9968	)
Change in operating assets and liabilities:
Prepaid expense and other assets		53,123			780
Accounts payable and other accrued liabilities		(18,553	)		56,399
Net cash (used in) operating activities		(226,549	)		(45,845	)
Cash flows from financing activities:
Operating proceeds from subsidiaries		–			200,000
Repayment of working capital advance to subsidiary		(1,150,000	)		–
Working capital advance from related party		–			–
Proceeds received from public or private offerings		–			–
Deferred offering costs incurred		–			(74,125	)
Net cash provided by financing activities		(1,150,000	)		125,875
Net (decrease) increase in cash and cash equivalents		(1,376,549	)		80,030
Cash and cash equivalents at beginning		2,177,414			14,621
Cash and cash equivalents at ending	$	800,865		$	94,651